2-72132389-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_019885.4(CYP26B1):āc.1377T>Cā(p.Ala459=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0616 in 1,610,962 control chromosomes in the GnomAD database, including 5,285 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.10 ( 1298 hom., cov: 33)
Exomes š: 0.057 ( 3987 hom. )
Consequence
CYP26B1
NM_019885.4 synonymous
NM_019885.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.97
Genes affected
CYP26B1 (HGNC:20581): (cytochrome P450 family 26 subfamily B member 1) This gene encodes a member of the cytochrome P450 superfamily. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The encoded protein is localized to the endoplasmic reticulum, and functions as a critical regulator of all-trans retinoic acid levels by the specific inactivation of all-trans retinoic acid to hydroxylated forms. Mutations in this gene are associated with radiohumeral fusions and other skeletal and craniofacial anomalies, and increased levels of the encoded protein are associated with atherosclerotic lesions. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 2-72132389-A-G is Benign according to our data. Variant chr2-72132389-A-G is described in ClinVar as [Benign]. Clinvar id is 1266263.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.97 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.212 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYP26B1 | NM_019885.4 | c.1377T>C | p.Ala459= | synonymous_variant | 6/6 | ENST00000001146.7 | NP_063938.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYP26B1 | ENST00000001146.7 | c.1377T>C | p.Ala459= | synonymous_variant | 6/6 | 1 | NM_019885.4 | ENSP00000001146 | P1 | |
CYP26B1 | ENST00000546307.5 | c.1152T>C | p.Ala384= | synonymous_variant | 5/5 | 1 | ENSP00000443304 | |||
CYP26B1 | ENST00000412253.1 | c.804T>C | p.Ala268= | synonymous_variant | 5/5 | 1 | ENSP00000401465 |
Frequencies
GnomAD3 genomes AF: 0.102 AC: 15450AN: 152104Hom.: 1281 Cov.: 33
GnomAD3 genomes
AF:
AC:
15450
AN:
152104
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0844 AC: 20830AN: 246832Hom.: 1821 AF XY: 0.0748 AC XY: 10025AN XY: 134106
GnomAD3 exomes
AF:
AC:
20830
AN:
246832
Hom.:
AF XY:
AC XY:
10025
AN XY:
134106
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0574 AC: 83711AN: 1458740Hom.: 3987 Cov.: 32 AF XY: 0.0558 AC XY: 40472AN XY: 725326
GnomAD4 exome
AF:
AC:
83711
AN:
1458740
Hom.:
Cov.:
32
AF XY:
AC XY:
40472
AN XY:
725326
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.102 AC: 15496AN: 152222Hom.: 1298 Cov.: 33 AF XY: 0.0995 AC XY: 7403AN XY: 74424
GnomAD4 genome
AF:
AC:
15496
AN:
152222
Hom.:
Cov.:
33
AF XY:
AC XY:
7403
AN XY:
74424
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
191
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 08, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at